LAB 2 CHAPTER 2

On March 7, 2012, Celgene Corporation acquired Avila Therapeutics, Inc.

Access Celgenes 2012 annual report and answer the following regarding the acquisition:

E) Prepare the entry Celgene would have made if Avila Therapeutics were dissolved after the combination.

F) Prepare the entry Celgene would have made if Avila Therapeutics continued as a separate wholly owned entity.

Please note - This was the only information given. There is no case or etc. supplements prior to this lab.